When.com Web Search

  1. Ads

    related to: who makes humalog

Search results

  1. Results From The WOW.Com Content Network
  2. Insulin lispro - Wikipedia

    en.wikipedia.org/wiki/Insulin_lispro

    Insulin lispro, sold under the brand name Humalog among others, is a modified type of medical insulin used to treat type 1 and type 2 diabetes. [5] It is delivered subcutaneously either by injection or from an insulin pump .

  3. Eli Lilly and Company - Wikipedia

    en.wikipedia.org/wiki/Eli_Lilly_and_Company

    The company also stated that it would lower the price of Humalog from $275 a month to $66 and that it would offer insulin glargine at a 78% discount compared to rival company Sanofi. Despite this, the reduced costs will not apply to Eli Lilly's newer brands of insulin, and the company's pricing is still significantly higher than it was several ...

  4. Lilly to Launch Cheaper Versions of Humalog KwikPen Insulins

    www.aol.com/news/lilly-launch-cheaper-versions...

    The lower-priced version of Humalog Mix75/25 will be known as Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 KwikPen (100 units/mL) while that of Humalog Junior KwikPen ...

  5. Insulin aspart - Wikipedia

    en.wikipedia.org/wiki/Insulin_aspart

    Insulin aspart, sold under the brand name NovoLog, among others, is a modified type of medical insulin used to treat type 1 and type 2 diabetes. [17] It is generally used by injection under the skin but may also be used by injection into a vein. [17]

  6. Is Eli Lilly Being Wise About YZ? - AOL

    www.aol.com/news/2013-02-19-is-eli-lilly-being...

    However, I don't think the company's YZ strategy will be enough over the next couple of years as it loses patent protection for Cymbalta and Humalog in 2013 and Evista in 2014. The three drugs ...

  7. Insulin (medication) - Wikipedia

    en.wikipedia.org/wiki/Insulin_(medication)

    1996 Lilly Humalog "lispro" insulin analogue approved. 2000 Sanofi Aventis Lantus insulin "glargine" analogue approved for clinical use in the US and the EU. 2004 Sanofi Aventis Apidra insulin "glulisine" insulin analogue approved for clinical use in the US. 2006 Novo Nordisk Levemir "detemir" insulin analogue approved for clinical use in the US.